LAS VEGAS, Jan. 14, 2024 /PRNewswire/ — TCL Electronics, a leading consumer electronics brand and the world’s top two TV brand, today announced that multiple of its products and technical solutions, including the 115-inch QM891G QD-Mini LED TV, smartphones and tablets with TCL’s new…
Month: January 2024
ACE y ACME en la implementación por fases de un proyecto que apunta a reciclar 20,000 toneladas métricas de baterías de plomo al año, con cero emisiones de Alcance 1. TAIPEI, 15 de enero de 2024 /PRNewswire/ — ACE Green Recycling (ACE) ha entregado con éxito la primera de las tres fases…
A ACE e a ACME avançam na implantação em fases para a reciclagem de 20.000 toneladas métricas de baterias de chumbo por ano com zero emissões de Escopo 1. TAIPEI, 15 de janeiro de 2024 /PRNewswire/ — A ACE Green Recycling (ACE) entregou com sucesso a primeira das três fases de sua…
ACE und ACME arbeiten an einer schrittweisen Einführung des Recyclings von 20.000 Tonnen Bleibatterien pro Jahr ohne Scope 1-Emissionen, also Emissionen aus Quellen, die direkt von Unternehmen verantwortet oder kontrolliert werden. TAIPEI, 15. Januar 2024 /PRNewswire/ — ACE Green…
ACE y ACME están avanzando en un despliegue gradual para reciclar 20.000 toneladas métricas de baterías de plomo al año con cero emisiones de Alcance 1 TAIPEI, 15 de enero de 2024 /PRNewswire/ — ACE Green Recycling (ACE) ha entregado con éxito la primera de las tres fases de su…
ACE et ACME progressent dans le déploiement progressif du recyclage de 20 000 tonnes métriques de batteries au plomb par an, sans aucune émission de type 1. TAIPEI, 15 janvier 2024 /PRNewswire/ — ACE Green Recycling (ACE) a livré avec succès la première des trois phases de sa technologie…
ACE & ACME are progressing on a phased deployment to recycle 20,000 metric tonnes of lead batteries per year with zero Scope 1 emissions. TAIPEI, Jan. 14, 2024 /PRNewswire/ — ACE Green Recycling (ACE) has successfully delivered the first of three phases of its proprietary zero-emissions…
SHANGHAI, Jan. 14, 2024 /PRNewswire/ — Hope Medicine Inc. (‘HopeMed’), a clinical-stage innovative biopharmaceutical company, announced recently that the company has completed a Phase Ib study, “An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with…
SHANGHAI, Jan. 14, 2024 /PRNewswire/ — Hope Medicine Inc. (‘HopeMed’), a clinical-stage innovative biopharmaceutical company, announced recently that the company has completed a Phase Ib study, “An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with…